Search form

Home
LoginSubscribe
  • Home
  • Country Intelligence
  • Industry Directory
  • Offsets / IC
  • Tenders
    • Haiti(0/week)
    • Guyana(0/week)
    • Honduras(0/week)
    • Jamaica(0/week)
    • Netherlands Antilles(0/week)
    • View all (0/week)
  • News
    • United States(944/week)
    • Manufacturing(432/week)
    • Technology(950/week)
    • Energy(323/week)
    • Environment(352/week)
  • Events
  • About us
    • Who we are
    • Our People
    • Partners
    • Contact us
  • LinkedIn
  • Login
  • Twitter
  • Register
  • Home
  • News

Sierra Oncology

Feb 12, 2021
Sierra Oncology Announces Presentation at LifeSci Partners Precision Oncology Day
Feb 09, 2021
Sierra Oncology Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
Jan 05, 2021
Sierra Oncology to Present at H.C. Wainwright 2021 BioConnect Virtual Conference
Dec 07, 2020
Sierra Oncology Announces Momelotinib Data for Intermediate / High-risk Myelofibrosis Patients with Lower Baseline Platelet Counts
Dec 05, 2020
Sierra Oncology Presents Long-term Overall Survival and Sustained Efficacy Outcomes Data for Momelotinib at ASH Annual Meeting
Dec 01, 2020
Sierra Oncology to Host KOL Panel Event to Discuss Updated Phase 3 Myelofibrosis Data Presented at ASH
Nov 25, 2020
Sierra Oncology Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
Nov 12, 2020
Sierra Oncology to Present at 2020 Jefferies Virtual London Healthcare Conference
Nov 05, 2020
Sierra Oncology to Report Momelotinib Long-term Overall Survival Data in Oral Presentation at ASH 2020
Nov 05, 2020
Sierra Oncology Reports Third Quarter 2020 Results
Oct 02, 2020
Sierra Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Sep 14, 2020
Sierra to Present at September Investor Conferences
Aug 06, 2020
Sierra Oncology Strengthens Management Team to Implement North American Pre-Commercialization Strategy for Momelotinib
Aug 06, 2020
Sierra Oncology Reports Second Quarter 2020 Results
Jun 12, 2020
Sierra Oncology Reports Favorable Long-Term Safety and Dose Intensity Data for Momelotinib
May 27, 2020
Sierra Oncology Announces Presentations at Upcoming Investor Conferences
May 26, 2020
Sierra Oncology Appoints Dr. Stephen Dilly as President and Chief Executive Officer
May 14, 2020
Sierra Oncology to Report Favorable Dose Intensity Data and Long-Term Safety Data for Momelotinib at the 25th European Hematology Association (EHA) Congress
May 07, 2020
Sierra Oncology to Hold KOL Call to Discuss Anemia & Transfusion Dependency as Critical Unmet Needs in Myelofibrosis
May 07, 2020
Sierra Oncology Reports First Quarter 2020 Results
  •  
  • Page 1
  • ››

Latest News

Jun 2, 2025

Faraday Future Holds First Annual Stockholders’ Day, Company Provides FX Product Updates, Confirms FX Super...

Jun 1, 2025

CARsgen Presents Research Results on Satri-cel in The Lancet and at the 2025 ASCO Annual Meeting

Jun 1, 2025

Europe's Moonshot Moment: New Industry Report Suggests Now is Europe's Time to Lead in Global...

Jun 1, 2025

Zareef Hamid on the Rise of AI-Native Organizations

Jun 1, 2025

Statement from Canada Post - Canada Post responds to CUPW's request for binding arbitration

Jun 1, 2025

Trevi Therapeutics to Host Conference Call and Webcast on June 2nd to Share Topline Results from the Phase 2b...

Jun 1, 2025

Ukraine strikes Russian bombers ahead of Istanbul talks

Jun 1, 2025

Russia says several military aircraft 'caught fire' in Ukraine drone attack

View all News

Agenda

30
September
PortugalTroia, Portugal
Seabed Security, 30 September - 01 October 2025, Troia, Portugal
Seabed Security | 30 September - 01 October 2025 | Troia, Portugal Defence iQ Announces Inaugural Seabed Security...
23
September
United KingdomLondon, UK
Countering Explosive Threat & Demining conference, September 23 - 24, 2025, London, UK
Countering Explosive Threat & Demining conference | September 23 - 24, 2025 | London, UK The Countering Explosive...
View All Events

SUBSCRIBE

to Epicos.com
Please register in order to have access to personalized daily information on world-wide A&D industry developments and business opportunities.
Subscribe

REGISTER

for Epicos.com Newsletter
Sign up for our free newsletters and receive twice a week news and intelligence regarding the Aerospace & Defence Industry, meticulously selected by our editorial team.
Sign Up
Home
  • SIGN UP FOR NEWSLETTER
  • NEWSLETTER ARCHIVE
  • ADVERTISE WITH US
  • CONTACT US
  • PRIVACY POLICY
  • INFORMATION SECURITY POLICY
© 2025 EPICOS
Made by Wedia